Drugs · acquisition-cost intelligence
COLACE EXTRA STRENGTH STOOL SOFTNER
Docusate Sodium· ingredient docusate· DOCUSATE SODIUM 250 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.05328
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other docusate products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| CVS Stool Softener Fruit Punch | $0.02113 | −$0.03210 |
| basic care stool softener | $0.02805 | −$0.02520 |
| DOK | $0.03872 | −$0.01460 |
| Colace | $0.25629 | +$0.20300 |
| Docusate Mini Enema | $0.40292 | +$0.34960 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.